Major Depressive Disorder

The Major Depressive Disorder pipeline: 67 tracked drugs, 9 approved for this indication.

9 approved / phase 412 Phase 32 Phase 2/335 Phase 21 Phase 1/26 Phase 12 preclinical / unstaged

Compare the share prices of listed companies in Major Depressive Disorder →

Total attributable cost

$127.3B

$6,429/patient

Drug spend

Not yet sourced

How this is calculated ↗

All severities (2019 claims-based estimate) · US

The Major Depressive Disorder pipeline

Key trial results for every approved and late-stage drug: Major Depressive Disorder results by drug.

← all assets